Endovastec

Name

Endovastec

Legal name

上海微创心脉医疗科技（集团）股份有限公司

Website

https://endovastec.com

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Sales: Sale of endovascular medical devices including aortic stent grafts, peripheral vascular stents and balloons, and tumor介入 products to hospitals through direct sales and distributor networks in domestic China and international markets.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Endovastec (心脉医疗) manufactures and sells interventional endovascular medical devices, including thoracic and abdominal aortic covered stent grafts, intraoperative stent systems, peripheral vascular stents and balloon catheters, drug-coated balloons, vena cava filters, embolization coils, and tumor embolization products. The company sells these products to hospitals through a direct sales force and provincial distributor network in China, and through international distributors in 30+ countries.

Product overview

Endovastec (心脉医疗) is a medical device company specializing in endovascular and peripheral vascular interventions. The company operates as a single unified product portfolio focused on three therapeutic areas: aortic diseases, peripheral vascular diseases, and tumor intervention. The core aortic product lines include Castor®/通天戈™ and Cratos®/通天镰™ branched aortic stent graft systems (the world's first one-piece branched devices), Talos®/通天眼™ thoracic stent grafts, Minos®/定海塔™ ultra-low profile abdominal stents, and Fontus®/通天刃™ and CRONUS®/通天刀™ intraoperative stent systems. The peripheral portfolio includes Reewarm® PTX/雪燕™ drug-coated balloons, peripheral stents (CROWNUS®/赤狐™, Veryan BM3D®), balloon dilation catheters, and venous products (Vflower®/海桥™ stent, Vewatch®/海神盾™ filter). Tumor intervention offerings include Tipspear®/穿云箭™ TIPS kits and FinderSphere®/夜明珠™ embolization microspheres. The company also distributes products from subsidiaries (蓝脉医疗 for venous, 鸿脉医疗 for peripheral arterial, 拓脉医疗 for tumor intervention) and agency products (Lombard Medical's Altura™ and Aorfix™).

Differentiator

Problem solved

Functional benefit

Brands

• Castor®/通天戈™: 分支型主动脉覆膜支架及输送系统 - 全球首款一体式分支型主动脉支架
• Minos®/定海塔™
• Cratos®/通天镰™
• Talos®/通天眼™
• Reewarm® PTX/雪燕™ PTX
• Vflower®/海桥™
• UniVas™

Products and services

• Castor®/通天戈™ Branched Aortic Covered Stent Graft and Delivery System The world's first one-piece branched aortic covered stent graft system for treating thoracic aortic dissection involving the left subclavian artery. Features integrated main body and branch design with unibody structure.
• Cratos®/通天锚™ Branched Aortic Covered Stent Graft System Next-generation branched aortic covered stent system for treating thoracic aortic dissection, serving as the successor to the Castor® platform. Features dual-release mode with rotational and quick-pull mechanisms and Active Birdbeak Control functionality.
• Talos®/通天眼™ Straight Thoracic Aortic Covered Stent Graft System Straight tube thoracic aortic covered stent graft system for Stanford B-type aortic dissection treatment, featuring a breathable design with distal perfusion holes.
• Hercules®/通天杖™ Low Profile Straight Tube Covered Stent and Delivery System Low profile straight tube aortic covered stent graft system for treating aortic aneurysms confined to straight vessel segments.
• Minos®/定海塔™ Abdominal Aortic Covered Stent and Delivery System Ultra-low profile abdominal aortic stent graft with 14F delivery system — the smallest profile in China's market. Features laser-cut hooks and single-wire braided limbs for stable anchoring.
• Aegis®/定海石® Bifurcated Aortic Covered Stent and Delivery System One-piece bifurcated aortic stent graft system for abdominal aortic aneurysms involving the common iliac artery. Enables personalized customization.
• Hercules®/定海柱™ Bifurcated Covered Stent and Delivery System Bifurcated stent graft system for abdominal aortic aneurysm endovascular treatment. Suitable for infrarenal abdominal aortic aneurysms with proximal neck greater than 15mm.
• Fontus®/通天刃™ Branched Intraoperative Stent System Branched intraoperative stent system for Stanford A-type and complex Stanford B-type aortic dissection surgery, enabling one-stage procedures that replace traditional two-stage surgeries.
• CRONUS®/通天刀® Intraoperative Stent System Intraoperative stent system for DeBakey Type I and partial Type III aortic dissection, replacing traditional elephant trunk surgery with one-stage procedures.
• Hercules®/通天锤™ Balloon Dilation Catheter Balloon dilation catheter for auxiliary expansion of aortic covered stents, ensuring proper stent deployment and eliminating endoleaks.
• L-REBOA®/通天盾™ Aortic Occlusion Balloon Catheter Aortic occlusion balloon catheter for temporary blood flow blockage; China's first domestically developed REBOA product for emergency aortic occlusion.
• Reewarm® PTX/雪燕™ PTX Drug-Coated Balloon Dilation Catheter Drug-coated balloon catheter for femoropopliteal artery PTA treatment of atherosclerotic stenosis or occlusive lesions. Features paclitaxel coating for targeted drug delivery.
• Reewarm®/云雀™ Peripheral Balloon Dilation Catheter Peripheral balloon dilation catheter for PTA treatment of iliac, femoral, superficial femoral, popliteal, and infrapopliteal arteries.
• ReeAmber®/蜂鸟™ Peripheral Balloon Dilation Catheter Next-generation peripheral balloon dilation catheter for iliac, femoral, popliteal, infrapopliteal, and renal artery stenosis, as well as AV fistula dialysis access stenosis.
• Ryflumen®/金刚™ Peripheral High-Pressure Balloon Dilation Catheter High-pressure peripheral balloon catheter for PTA of peripheral vascular system including iliac, femoral, popliteal, tibial, peroneal, subclavian, and renal arteries.
• SeaDragon®/海龙™ Peripheral Balloon Dilation Catheter China's first domestically developed braided ultra-high pressure peripheral balloon catheter for peripheral vasculature including iliac and iliofemoral veins.
• CROWNUS®/赤狐™ Peripheral Vascular Stent System Peripheral vascular stent system for treating iliac, femoral, and subclavian artery stenosis or occlusion, including PTA restenosis or occlusion.
• SunFlow™/雪豹™ Drug-Eluting Peripheral Arterial Stent System Dual-layer targeted drug-eluting peripheral arterial stent system with unique drug spray coating process and compound open/closed loop stent design for complex peripheral lesions.
• Vflower®/海桥™ Venous Stent System Venous stent system for iliofemoral vein treatment of non-thrombotic iliac vein compression syndrome, deep vein thrombosis, and post-thrombotic syndrome; designated as a national innovative medical device.
• Vewatch®/海神盾™ Vena Cava Filter Vena cava filter for pulmonary embolism prevention via femoral or jugular vein approach, with multiple clinical indications including PE with DVT.
• Vepack®/海神索™ Filter Retriever Filter retriever consisting of grasper and sheath/dilator components for percutaneous removal of inferior vena cava filters.

Quantifiable outcome

• 外周动脉介入市场广阔发展空间 | 国内仅2款药物洗脱外周动脉支架上市，均为进口产品
• +2 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Fudan University Zhongshan Hospital - Prof. Fu Weiguo TeamcoreStrategic or Co-development Partner · 20 May 2026Clinical collaboration for first-in-human implantation of Zelus™定制胸腹主动脉覆膜支架. Professor Fu Weiguo's vascular surgery team serves as clinical development partner for complex aortic disease treatments.
• China Medical Academy Fuwai Hospital - Prof. Shu ChangcoreStrategic or Co-development Partner · 1 January 2026Professor Shu Chang provides guidance and support for international clinical applications and product launches, including Cratos® first clinical implantation in Macau.
• Korea and Turkey Clinical CentersminorStrategic or Co-development Partner · 1 January 2025Signed international academic cooperation MOUs with clinical centers in Korea and Turkey to build Asia-Pacific and Eurasian academic training exchange platform.
• Optimum Medical (Europe)minorStrategic or Co-development Partner · 1 August 2024Acquired 72.37% equity in European medical device company, completed in August 2024. Part of European market expansion strategy.
• Lombard Medical (UK)coreStrategic or Co-development Partner · 1 January 2024European subsidiary acquired in 2024. Serves as the company's European market business center and operational hub, supporting global development strategy. Located in Oxfordshire, UK.
• Veryan Medical (代理合作)minorChannel Partner/ Reseller/ Distributor · 1 January 2024Distribution partnership for Veryan BM3D® peripheral stent system in China. Product is global首款且唯一, approved by NMPA in September 2024.
• Shanghai Shangshan Public Welfare Foundation (上海上善公益基金会)minorStrategic or Co-development Partner · 15 February 2022Jointly established '心脉益行' (Xinmai Yixing) dedicated fund for providing charitable medical assistance to impoverished patients with aortic diseases. The program has helped over 50 patients as of 2023.

Scale indicators10 records

Recent moves3 records

Direct peers

• Artivion (formerly CryoLife): Specialty cardiac and vascular surgery company with the JOTEC aortic stent graft portfolio (acquired 2021) and BioGlue surgical adhesive; competes in aortic stent grafting and peripheral vascular intervention.
• Lifetech Scientific: China-based, Shenzhen-listed peer specializing in structural heart and peripheral vascular interventional devices including aortic stent grafts and occluders; most direct Chinese domestic comparable to Endovastec in endovascular implants.

Emerging players

• Penumbra: Specializes in mechanical thrombectomy (Indigo system) and peripheral vascular intervention; competes with Endovastec's Fishhawk® thrombectomy device in the venous/peripheral DVT treatment category.
• Veryan Medical: Developer of the BM3D® 3D-helical peripheral stent — now distributed in China by Endovastec under a partnership; comparable through the BioMimics 3D technology that overlaps with Endovastec's peripheral arterial franchise.

Others

• MicroPort Scientific: Parent company of Endovastec; operates adjacent cardiovascular, orthopedic and endovascular device businesses. Relevant as the controlling shareholder and as an indirect competitor through overlapping medtech franchises.

Broad incumbents

• B. Braun: Diversified medical device manufacturer with an interventional vascular portfolio (angioplasty balloons, stents, and dialysis access products); competes with Endovastec in peripheral arterial and venous intervention.
• Cook Medical: Long-established player in endovascular aortic repair with the Zenith stent graft platform and a broad peripheral intervention portfolio; competes with Endovastec across both aortic and peripheral vascular categories globally.
• Medtronic: Global leader in endovascular interventions with the Endurant abdominal aortic stent graft and Valiant thoracic stent graft systems — directly competing with Endovastec's Hercules/Minos/Talos product lines in the aortic and peripheral vascular categories worldwide.
• Terumo: Diversified medical device company with the Relay thoracic stent graft (acquired from Bolton Medical) and a growing peripheral vascular and interventional franchise; competes with Endovastec in aortic and peripheral interventions.
• W. L. Gore & Associates: Manufacturer of the Gore Excluder abdominal aortic stent graft and TAG thoracic device using proprietary ePTFE graft technology; competes head-to-head with Endovastec in the EVAR/TEVAR market.

Market position

Strengths5 records

Weaknesses5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/shanghai-microport-endovascular-medtech-co-ltd

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries5 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Endovastec